chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sleepwalked outside of his home and urinated in his front yard; Sleepwalked outside of his home and urinated in his front yard; This is a spontaneous report from a contactable consumer (patient). A 33-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number was not reported), via an unspecified route of administration in left arm, on 01Mar2021 at 10:30 AM (at the age of 33 years), as first dose, single dose, for COVID-19 immunization. The patient's medical history included diabetes type 1. The patient's concomitant medications included insulin, Monascus purpureus (RED YEAST RICE), arginine (L ARGININE), apple cider vinegar, and fish oil. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The day of the vaccination, the patient was taking insulin, red yeast rice, l-arginine, apple cider vinegar, and fish oil. The night after the patient got the vaccine, he sleepwalked outside of his home and urinated in his front yard on 02Mar2021 at 06:00 AM. The patient had never slept walked before. The adverse events resulted in doctor or other healthcare professional office or clinic visit. No treatment was administered for the events. The patient had not been tested for COVID-19 post vaccination. The patient had not recovered from the events.  No follow-up attempts are possible. No further information is expected.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Apr2021 at 10:00 as dose 2, single (Batch/Lot number: unknown) at the age of 56 years, in left leg for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing); "Diabetes" (unspecified if ongoing); "High Cholesterol" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of covid-19, drug ineffective.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Post vax, around 19:00 the next day, pt had fever spiked up to 104F. Child started seizure around 20:00, tonic/clonic, seized for 2 hours in hospital. Sedated in ER and sent to another hospital for 2 days. Dx'd with febrile seizure.
Approx. 20 minutes after injection small (penny size) welt appeared where MMR was given - mom advised to place cool compress on area and call if swelling increases.
Reported headache and twitching of right cheek. Took Tylenol and headache resolved day of vaccination; twitching resolved day of vaccination (unknown duration).  12/23/20 (day after vaccination) he reported a slight headache upon awakening that worsened as the day passed. He took 2 extra strength Tylenol at 10:00 AM (12/23/20).  Tylenol partially effective - headache lessened but still present.  12/28/20 update - chills, nausea, and fatigue from 12/23 - 12/28. Improvement in symptoms but symptoms are not completely resolved as of 12/28/20 per patient.
Remained with baseline redness/swelling from time of injection (3/16/12) until 2 days ago when he began c/o increased pain, swelling, redness & warmth. No fevers. Today has area of redness/swelling 4cm x 3.3cm. Prescribed AUGMENTIN ES & BACTROBAN.
blurry vision; double vision; This is a spontaneous report from a non-contactable consumer. This consumer reported same events for two patients. This is first of two reports. A 7 decades old female patient received bnt162b2, via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced blurry vision, double vision on an unspecified date. The reporter told that her elderly aunt and uncle (ages 60+ and 80+) received the Pfizer vaccine and experienced blurry vision and double vision. The outcome of events was resolving.   Information about Lot/Batch number is requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021015734 same reporter/drug/AE with different patient
BRAIN FOG; WEAKNESS IN ARMS AND LEGS; FEELING UNWELL; EXTREME FATIGUE; NUMBNESS IN FACE, HANDS AND LEGS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811 expiry: UNKNOWN) dose was not reported, administered on 14-OCT-2021 for prophylactic vaccination. No concomitant medications were reported. On 19-OCT-2021, the patient experienced brain fog. On 19-OCT-2021, the patient experienced weakness in arms and legs. On 19-OCT-2021, the patient experienced feeling unwell. On 19-OCT-2021, the patient experienced extreme fatigue. On 19-OCT-2021, the patient experienced numbness in face, hands and legs. Laboratory data (dates unspecified) included: CT scan (NR: not provided) Not reported, and Laboratory test (NR: not provided) Not reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from brain fog, weakness in arms and legs, numbness in face, hands and legs, extreme fatigue, and feeling unwell. This report was non-serious.
afternoon day of vax c/o mild abd cramping;that evening was out running & had serious abd cramping;went to bed 830PM not feeling well;T99.4 po;woke @ 0100;father stated having auditory hallucination;T100.2;anxious & fearful x2hr;
8:15 pm - start of shivering and headache, right side tension in shoulder and neck  10:30 pm - 103° temp, continued body shakes, muscle aches, headache, (flu like symptoms)  10:00 am on 3/13/21 - low grade temp, sweats, headache, sore arm
Pt c/o of chest pain. Works out a lot. Point tenderness, very anxious. Vital signs at 10:45am 160/98, HR 133, RR 22. Rechecked at 11:00am, BP 140/92, HR 90. Refused to allow calling his wife. Pt transported to hosptial. Follow up call made but no answer.
Mom thinks cognition was disturbed after VARIVAX. Some behavioral problems. Day 3- Still having problems according to mom.
15 hours after - onset massive body and skin aches, tingling/burning skin, migraine-level headache.   25 hours after: swelling and rash at injection site radiating to elbow and around entire upper arm.   48 hours after: swelling and bruising through lymph nodes under left arm. Less than 5 hours? sleep, skin sensitivity lasted through first 48 hours. Became reliant on inhaler for minor exertion or activity.   72 hours after: insomnia continued, pain & swelling  & rash through lymph nodes continued. Bruising in upper arm continued. By Sunday evening (3rd day), began having hallucinations and uncontrollable feelings of rage, led to contacting suicide hotline.  Feelings were not resolved  with 2 1mg doses of clonipin over 5 hours. Couldn?t reach a live person at suicide hotline and ended up driving to ER for dose of Atavan, where I finally slept.
I've lost 16 pounds in 1 month and 20 days without trying.  Moderna killed my obsession for food.  I was 268 lbs when I presented for the 1st dose of Moderna at the Robeson CRV.  Within 24 hours I was weak, cold, aching all over, and nauseous. The nausea moved over to lack of interest in food.     I've struggled with intense craving for food non-stop for 30 years.  The cravings are gone.  By my second shot in March I was down to around 260 lbs.  Twenty days after my second shot, I am down to 252lbs.  Food is more of a necessity now rather than a constant desire.  I believe the vaccine modulated insulin/ghrelin or crossed the blood brain barrier and modulated the incessant dopamine reward signaling in the mesolimbic DA pathway when I eat food.  I reach satiety easily now.  I also have diminished need for Ativan.  I use to drink close to a gallon of water a day.  Now I have no real interest.  I might drink a couple liters a day.  To put things in perspective, before Moderna, I could eat 2 foot long Subway sandwiches, 3-6 cookies, 2-4 32 oz of soda and chips to stop my hunger for 2-3 hours.  2-3 hours later I would feel extremely hungry with a growling stomach. I could then consume 2-3 double cheeseburgers, a 20 piece nugget, 2 parfaits, and a chocolate sundae.  After Moderna, now a half a Subway sandwich and maybe a cookie are enough to last for most of the day.  The desire for food has diminished to necessity to eat and lack of interest in eating, even when my stomach is empty.  If I have a soda or sparkling water, I might have 1 or 2 and stop.  Moderna flipped some hormonal switch in my body.  It's great.  Food went from being an insatiable desire to a basic necessity.  I've lost 16 pounds in 1 month and 20 days without trying.
Extreme Tinnitius. I self treated with ringing in the ear, ear drops and OTC ringing in the ear supplements. I discussed it with a TelaDoc Doctor who referred to see a physician in person. May 25th, I saw an ENT Specialist who said their was no fluid in my ear, nor any issue with my vestibular organ. I had a hearing test that showed moderate loss of hearing and he recommended hearing aids. I also had disequilibrium issues and started seeing a chiropractor who helped with that. The tinnitus has continued and is at times piercing and painful. 09/09/21 I saw a PCP who prescribed Methlpred 4mg therapy pak. Finished yesterday, tinnitus still strong and varies.
TO ER on 5/7/06. On 5/1/06 pt with laceration to Right hand vaccinated with TD left deltoid 5/1, pt stated increased pain redness, swelling on 5/3 left deltoid, pt states fever 5/5 and pain increasing on entire LUE. Pt put a home remedy (oil like substance) on affected area. (heated it up an put on gauze) pt with 2 and 1 degree burn over injection site. Pt left ER AMA.
Daughter reporting after her mother's death .  She got her vaccine and called her daughter in the afternoon around 2:00 and told her that she got it.  At 6:00 she received a VM where she said that she was having joint pain and wanted to know if she could call her doctor to get her joint pain medicine.  Later that evening her daughter told her that was why she was put on the Hydroxychloroquine and they wanted her to see the rheumatologist.  She complained of pain a lot, but she specifically asked for joint pain medicine.  On the 22nd on another VM her daughter noticed that she sounded raspy hoarse sounding and congested and had a cough.  Then subsequent messages after that the hoarseness was there that didn't go away.  Her daughter took her to the dentist on 4/15/21 and she remembered that the caregiver told her that she did not want to go to the dentist as she did not feel good.  She did not like to get out of the apartment.  Then on 4/19/21 she was admitted to the hospital and that she had pneumonia.  They were going to discharge her home and she was going to pick her up on 4/22/21, and then they called her back and told her that she sounded junky and they were going to keep her another day.  She made arrangements to pick her up on Friday and then her oxygens dropped and would discharge her on Monday.    She normally gets oxygen 1 liter of oxygen only at night, and when she was admitted her oxygen levels were low and they put her on 6 liters when she was admitted.  Then she was weaned off oxygen completely, and her daughter informed them that she slept with oxygen and that's when they were talking about going home.  On Friday she dropped her oxygen level into the 60's  On Saturday 4/24/21 she was on 9 liters of oxygen and the doctor came in and said that she was on 14.  By Saturday night she was on the Critical care Unit, but her on Vancomycin and was on Vapotherm on high-flow oxygen and she had maxed out at 40 liters at 100% oxygen.   They talked to the daughter about putting her on ventilation and thought it was toxicity to Vancomycin and other things and couldn't figure it out and said that it was some sort of inflammation of her lungs.  They put her on high levels of steroids and was then taken off of high-flow oxygen and then was still on 20% liters.  They recommended hospice and palliative care.  They decided to bring her home on Hospice with 15 liters of oxygen.  It was up and down levels.  She was given steroids when she came home on Hospice and was given steroids.  She then started to decline and hospice nurse came and she was admitted to Hershey and they repeated her chest x-ray and COVID testing, and that her lungs were so scarred there was nothing that they could do for her.  They tested her for COVID multiple times, the CAT Scans came back that it was worsening and consistent with COVID but tested negative twice while was there.  She was then sent to Hospital and tested again and was negative, and she passed on 5/10/2021.    HOSPITAL ADMISSIONS: She was admitted to  on 4/19/21 discharged home on hospice on 5/6/21.    She was admitted to Medical Center on 5/6/21 and she died on 5/10/21 at 5:48 PM.
This spontaneous report as received from a registered nurse refers to multiple unspecified patients of unknown age and gender. No information regarding the patients' medical history, concurrent conditions and concomitant medications was provided. On unknown dates, the patients were vaccinated with doses of improperly stored VARIVAX (Merck), (dose, route of administration, injection site, lot number and expiration date were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
SORE ARM AT INJECTION SITE RESOLVED IN 48 HOURS. Narrative:
An adult dose of Pfizer (0.3 mL) was retrieved for an adult patient who was to be vaccinated at the start of the clinic. The adult patient walked away without being vaccinated after being checked in and a pediatric patient was brought to the table next. The patient was a 10-year-old male weighing 145.2 lbs. The clinician had a scribe who verified the date of birth with the parent. The clinician did not hear the DOB, grabbed the adult dose (0.3 mL) on the table, and vaccinated the pediatric patient thinking he was 12-years-old based on weight. The original adult patient who stepped away returned and the clinician asked for another adult dose of Pfizer, at which point the error was discovered. The patient was identified immediately and was still in observation with a parent. The parent was notified and counseled about potential adverse/side effects. The patient was monitored for an additional 15 minutes (30 minutes total). The parent was also advised that the patient should still return in 21 days for the second dose and that he would be receiving the pediatric dose (0.2 mL) at that time.
Received routine 15 month vaccinations. 3rd day after varicella vaccine-pt developed a 5 inch 2 3/4 inch red, hot reaction. Pt. treated with Benadryl 1 tsp every 6 hours, cool compresses.
Rash, hives and redness, and swelling of the arms that soon improved with benadryl
Patient (came in with father) did not give proper age because they wanted to get the 1 dose J&J. It was not until after vaccinating the patient and we were processing the vaccine that we learned that she was not 18. We spoke with patient and her parent, and they apologized for giving us the wrong DOB.
Case number PHEH2013US022979 is an initial spontaneous report from consumer (patient) received on 31 Oct 2013. This case refers to 59-year-old male patient. He was vaccinated with FLUVIRIN (batch number: not reported) intramuscularly on an unspecified date in Aug 2012. On an unknown date, within two weeks after the vaccination, he developed rheumatoid arthritis. He had been seeing a rheumatoid specialist since Apr 2013. The patient had got FLUVIRIN vaccination around 01 Oct 2013 and developed rheumatoid arthritis again (see case: PHEH2013US022985). The seriousness, outcome and causality of event were not reported.
I had sever abdominal pain and fever. I could not keep even water down. I had severe diarrhea.
patients that were vaccinated with this vaccine after the excursion; No adverse event; patients that were vaccinated with this vaccine after the excursion; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (patients that were vaccinated with this vaccine after the excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (patients that were vaccinated with this vaccine after the excursion) and NO ADVERSE EVENT (No adverse event) in a 58-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7162B) for COVID-19 prophylaxis.     Concurrent medical conditions included Hypothyroidism and Penicillin allergy.    On 07-Oct-2022 at 11:17 AM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 07-Oct-2022 at 11:17 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (patients that were vaccinated with this vaccine after the excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients that were vaccinated with this vaccine after the excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (patients that were vaccinated with this vaccine after the excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (patients that were vaccinated with this vaccine after the excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (patients that were vaccinated with this vaccine after the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (patients that were vaccinated with this vaccine after the excursion).    No concomitant medication was reported.  It was unknown if the patient had ever been diagnosed or tested positive for COVID-19.  Acute illness at the time of vaccination and up to one month before was unknown.  It was reported that Moderna bivalent vaccine was administered after a temperature excursion. Patient did not report any adverse events.   No treatment information was provided.
Titers for Measles did not respond to adequate for entry into country with parents following father's assignment in another country. Was triple-immunized for Measles in order for titer response. Extreme (savant) Hyperlexia noted during 2-3 yrs old, multiple allergies developed during childhood.
Pain at injection site after 6 hours followed by malaise, fatigue, upper body muscle soreness, chills, feeling hot which started 12 bourse after the shot and lasted till 3 days after shot. Partially improved symptoms with ibuprofen 600mg but short lasting.
developed reddish-brown, irregular shaped circles on her foot and ankle; like hemorrhaging underneath the skin; now the marks or a yellowish white color.; This spontaneous case was reported by a physician and describes the occurrence of ERYTHEMA (developed reddish-brown, irregular shaped circles on her foot and ankle), SKIN HAEMORRHAGE (like hemorrhaging underneath the skin) and VACCINATION SITE DISCOLOURATION (now the marks or a yellowish white color.) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included Diabetes. Concomitant products included AMLODIPINE, GLIMEPIRIDE, METFORMIN and ACETYLSALICYLIC ACID (ASPRIN) for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (developed reddish-brown, irregular shaped circles on her foot and ankle), SKIN HAEMORRHAGE (like hemorrhaging underneath the skin) and VACCINATION SITE DISCOLOURATION (now the marks or a yellowish white color.). At the time of the report, ERYTHEMA (developed reddish-brown, irregular shaped circles on her foot and ankle) and VACCINATION SITE DISCOLOURATION (now the marks or a yellowish white color.) outcome was unknown and SKIN HAEMORRHAGE (like hemorrhaging underneath the skin) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details was not reported by the reporter.
Moderna Dose 1 5/8/21 (026B21A) Moderna Dose 2 6/9/21 (038B21A) COVID Positive 2/6/22  2/6/22: This is a 65-year-old male with history of obesity, coronary artery disease status post stenting in the past, hyperlipidemia and type 2 diabetes mellitus who presented to the emergency department with pain in the left shoulder. Patient has been having worsening left shoulder pain for the past few days. Pain is moderate to severe intensity, radiates down the left arm, pressure-like, without noticeable relieving or exacerbating factors. There is associated shortness of breath and dizziness. He has no fever, chills, cough, vomiting or abdominal pain. Patient has history of coronary artery disease and had stents placed in 2001. He is on p.o. aspirin 81 mg daily at home. He has not been following with Cardiology since then.   In the emergency department, patient had an EKG that showed ST elevations in the inferior leads. He was noted to be in sinus bradycardia.  His E had a negative troponin level. He received 4 p.o. aspirin tablets prior to coming to the emergency department. Patient was started on IV heparin drip. Cardiology was consulted and he was taking to the cath lab.  2/9/22: Dual anti-platelet therapy per Cardiology with p.o. aspirin and Brilinta  P.o. amiodarone 200 mg daily  P.o. atorvastatin 80 mg daily  P.o. Eliquis for DVT prophylaxis  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Follow up with Cardiology as outpatient  Patient and wife agree with plan of care
Patient received shingles vaccine on 10/23/2019. Patient said pain happened for a few days then it turned into soreness and tenderness. Patient reports that he is not able to raise arms above head and that he has trouble rotating arms. Patient received second dose on 1/20/20 and experienced same symptoms in other arm. Patient also reports pain in hand around thumb joint in palm of hand since injections.
PATIENT CAME BACK AFTER THREE WEEKS TO REPORT THAT SHE HAS BEEN GETTING PAIN, AND TINGLING SENSATION OF HER ARM AND RASH ON THE AREA OF THE INJECTION